Cartazolate (SQ-65,396) is a drug of the pyrazolopyridine class. It acts as a GABAA receptor positive allosteric modulator at the barbiturate binding site of the complex and has anxiolytic effects in animals. It is also known to act as an adenosine antagonist at the A1 and A2 subtypes and as a phosphodiesterase inhibitor. Cartazolate was tested in human clinical trials and was found to be efficacious for anxiety but was never marketed. It was developed by a team at E.R.

PropertyValue
dbpedia-owl:abstract
  • Cartazolate (SQ-65,396) is a drug of the pyrazolopyridine class. It acts as a GABAA receptor positive allosteric modulator at the barbiturate binding site of the complex and has anxiolytic effects in animals. It is also known to act as an adenosine antagonist at the A1 and A2 subtypes and as a phosphodiesterase inhibitor. Cartazolate was tested in human clinical trials and was found to be efficacious for anxiety but was never marketed. It was developed by a team at E.R. Squibb and Sons in the 1970s.
dbpedia-owl:atcPrefix
  • none
dbpedia-owl:casNumber
  • 34966-41-1
dbpedia-owl:fdaUniiCode
  • 8K93Z46WPY
dbpedia-owl:iupacName
  • ethyl 4-(butylamino)-1-ethyl-1H-pyrazolo3,4-bpyridine-5-carboxylate
dbpedia-owl:pubchem
  • 37015
dbpedia-owl:thumbnail
dbpedia-owl:wikiPageID
  • 28642033 (xsd:integer)
dbpedia-owl:wikiPageInLinkCount
  • 5 (xsd:integer)
dbpedia-owl:wikiPageOutLinkCount
  • 22 (xsd:integer)
dbpedia-owl:wikiPageRevisionID
  • 543888627 (xsd:integer)
dbpprop:atcPrefix
  • none
dbpprop:c
  • 15 (xsd:integer)
dbpprop:casNumber
  • 34966 (xsd:integer)
dbpprop:chemspiderid
  • 33966 (xsd:integer)
dbpprop:h
  • 22 (xsd:integer)
dbpprop:hasPhotoCollection
dbpprop:iupacName
  • ethyl 4--1-ethyl-1H-pyrazolo3,4-bpyridine-5-carboxylate
dbpprop:legalStatus
  • Uncontrolled
dbpprop:molecularWeight
  • 290.360000 (xsd:double)
dbpprop:n
  • 4 (xsd:integer)
dbpprop:o
  • 2 (xsd:integer)
dbpprop:pubchem
  • 37015 (xsd:integer)
dbpprop:routesOfAdministration
dbpprop:smiles
  • O=COCC
dbpprop:unii
  • 8 (xsd:integer)
dcterms:subject
rdf:type
rdfs:comment
  • Cartazolate (SQ-65,396) is a drug of the pyrazolopyridine class. It acts as a GABAA receptor positive allosteric modulator at the barbiturate binding site of the complex and has anxiolytic effects in animals. It is also known to act as an adenosine antagonist at the A1 and A2 subtypes and as a phosphodiesterase inhibitor. Cartazolate was tested in human clinical trials and was found to be efficacious for anxiety but was never marketed. It was developed by a team at E.R.
rdfs:label
  • Cartazolate
owl:sameAs
http://www.w3.org/ns/prov#wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is owl:sameAs of
is foaf:primaryTopic of